LifeVantage Corporation
LFVN · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 1.33 | -1.29 | -0.24 |
| FCF Yield | 6.56% | 12.70% | 6.89% | 11.47% |
| EV / EBITDA | 9.88 | 9.47 | 10.83 | 5.30 |
| Quality | ||||
| ROIC | 20.15% | 7.03% | 5.46% | 2.46% |
| Gross Margin | 80.37% | 79.30% | 79.67% | 81.54% |
| Cash Conversion Ratio | 1.21 | 1.21 | 2.69 | 2.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.31% | -1.01% | -1.04% | -3.95% |
| Free Cash Flow Growth | 5.58% | 164.61% | -41.50% | -48.70% |
| Safety | ||||
| Net Debt / EBITDA | -0.56 | -0.41 | -2.00 | -0.45 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 185.90 |
| Efficiency | ||||
| Inventory Turnover | 2.17 | 2.75 | 2.70 | 2.31 |
| Cash Conversion Cycle | 137.01 | 87.00 | 108.90 | 95.33 |